A novel clinical method to measure skin staining reveals activation of skin damage pathways by cigarette smoke.

Abstract

BackgroundLong‐term use of cigarettes can result in localised staining and aging of smokers’ skin. The use of tobacco heating products (THPs) and electronic cigarettes (ECs) has grown on a global scale; however, the long‐term effect of these products’ aerosols on consumers’ skin is unknown. This pilot clinical study aimed to determine whether THP or EC aerosol exposure results in skin staining or activation of biomarkers associated with oxidative stress.Materials and methodsEight areas were identified on the backs of 10 subjects. Two areas were used for air control, and two areas exposed to 32‐puffs of cigarette smoke (CS), THP or EC aerosols, which were delivered to the skin using a 3‐cm diameter exposure chamber and smoke engine. Skin colour was measured using a Chromameter. Squalene (SQ), SQ monohydroperoxide (SQOOH) and malondialdehyde (MDA) levels were measured in sebum samples by mass spectrometry and catalase colorimetry.ResultsCS exposure significantly increased skin staining, SQOOH and MDA levels and SQOOH/SQ ratio. THP and EC values were significantly lower than CS; EC values being comparable to air control. THP values were comparable to EC and air control at all endpoints, apart from skin staining. SQ and catalase levels did not change with exposure.ConclusionsCS stained skin and activated pathways known to be associated with skin damage. THPs and ECs produced significantly lower values, suggesting they could offer hygiene and cosmetic benefits for consumers who switch exclusively from smoking cigarettes. Further studies are required to assess longer‐term effects of ECs and THPs on skin function.